According to Gram Research analysis, a 2026 study found that Shenfu Qiangxin pill, a traditional Chinese herbal medicine, improved heart function and reduced scarring and inflammation in mice with a difficult-to-treat type of heart failure called HFpEF. The herbal remedy worked by simultaneously fixing multiple types of heart cells—reducing harmful immune responses, preventing excessive scarring, and improving fluid drainage. While these results are promising, the study was conducted in mice, and human clinical trials are needed before this treatment can be recommended for patients.
Researchers discovered how a traditional Chinese herbal medicine called Shenfu Qiangxin pill (SFQX) helps treat a serious type of heart failure that’s difficult to manage with standard medications. Using advanced genetic technology, scientists found that the herbal remedy works by fixing multiple problems in heart cells at once—reducing inflammation, decreasing scarring, and improving how the heart pumps fluid. The study used mice with heart failure and found that SFQX improved heart function and reduced dangerous fluid buildup. This research bridges ancient healing practices with modern science, suggesting that treating complex diseases might require multi-targeted approaches rather than single-drug solutions.
Key Statistics
A 2026 research study found that Shenfu Qiangxin pill reduced fibrosis (heart scarring) and inflammation while improving cardiac function in mice with HFpEF, a type of heart failure that is difficult to treat with current medications.
According to single-cell genetic analysis in a 2026 study, the herbal medicine Shenfu Qiangxin pill reprogrammed multiple types of heart cells simultaneously, including immune cells, fibroblasts, and endothelial cells, to reverse pathological changes in heart failure.
A 2026 animal study demonstrated that Shenfu Qiangxin pill reduced myocardial edema (dangerous fluid buildup in heart muscle) and enhanced lymphatic drainage capacity in mice with HFpEF by modulating cellular heterogeneity.
The Quick Take
- What they studied: How a traditional Chinese herbal medicine (Shenfu Qiangxin pill) treats a specific type of heart failure called HFpEF, which is difficult to treat with current medications
- Who participated: Laboratory mice were given a high-fat diet and a chemical to create heart failure similar to the human condition, then treated with the herbal medicine
- Key finding: The herbal remedy improved heart function and reduced inflammation, scarring, and fluid buildup by fixing multiple types of heart cells simultaneously
- What it means for you: This research suggests that traditional herbal medicines may work differently than modern single-drug treatments by addressing multiple problems at once. However, these findings are from animal studies and need human testing before people should consider this treatment
The Research Details
Scientists used advanced genetic technology called single-cell RNA sequencing to examine individual heart cells and understand exactly how the herbal medicine worked. They created heart failure in mice using a high-fat diet combined with a chemical that damages heart function, mimicking the human disease. The mice were then treated with Shenfu Qiangxin pill, and researchers compared their heart cells to untreated mice to see what changed.
The researchers also identified the active ingredients in the herbal medicine using a technique called mass spectrometry, which is like a fingerprint reader for chemicals. This helped them understand which components of the complex herbal formula were responsible for the benefits.
The study combined multiple approaches: genetic analysis of individual cells, measurements of heart structure and function, and examination of inflammation and scarring in heart tissue. This multi-layered approach allowed researchers to see the complete picture of how the medicine affected the heart at different levels.
This research approach is important because heart failure with preserved ejection fraction (HFpEF) is complex and involves problems in multiple types of heart cells working together. Traditional treatments often target only one problem, which is why they don’t work well for everyone. By examining individual cells, researchers could see that the herbal medicine fixes several problems simultaneously—like a mechanic who fixes multiple broken parts in an engine rather than just one. This explains why traditional herbal formulas, which contain many ingredients, might be better suited for complex diseases than single-drug treatments.
This study used cutting-edge genetic technology (single-cell RNA sequencing) that provides detailed information about how individual cells respond to treatment. The researchers validated their findings using multiple methods, not just genetic analysis. However, this is an animal study using mice, not humans, so results may not directly apply to people. The study was published in a peer-reviewed journal, meaning other scientists reviewed it before publication. The main limitation is that we don’t yet know if these results will work the same way in human patients.
What the Results Show
The herbal medicine Shenfu Qiangxin pill improved heart function and structure in mice with heart failure. Specifically, the treatment reduced the amount of scarring (fibrosis) in heart tissue and decreased inflammation—two major problems in HFpEF. The medicine also reduced dangerous fluid buildup in the heart muscle (myocardial edema), which is a serious complication of heart failure.
At the cellular level, the herbal remedy worked by reprogramming multiple types of heart cells. It changed how immune cells behaved, reducing harmful inflammation. It normalized the different states of fibroblasts (cells that create scar tissue), preventing excessive scarring. It improved how endothelial cells (blood vessel lining cells) used energy, and it restored proper function of lymphatic vessels that drain fluid from the heart.
These changes happened because the herbal formula contains multiple active ingredients that work together on different cell types. Rather than one ingredient doing one job, the combination of ingredients creates a coordinated effect across the entire heart tissue. This multi-targeted approach appears to be why the traditional formula was effective for a complex disease like HFpEF.
The researchers identified the major active chemical compounds in the herbal medicine using mass spectrometry analysis. This revealed which ingredients were likely responsible for the therapeutic effects. The study showed that the herbal medicine improved lymphatic drainage capacity—the heart’s ability to remove excess fluid—which is particularly important in HFpEF where fluid accumulation is a major problem. The treatment also enhanced the metabolic flexibility of endothelial cells, meaning these cells could adapt better to changing energy demands.
Current standard treatments for HFpEF have limited effectiveness, with many patients continuing to experience symptoms despite medication. This research suggests that traditional Chinese medicine approaches, which use multiple ingredients targeting different pathways, may offer a different strategy than conventional single-drug treatments. Previous research has shown that HFpEF involves problems in multiple cell types, but most modern medications focus on one target. This study supports the traditional medicine principle that complex diseases require complex, multi-component solutions. However, no direct comparison was made between SFQX and standard HFpEF medications in this study.
This study was conducted in mice, not humans, so results may not directly translate to people. The sample size of mice used was not specified in the abstract. The study did not compare the herbal medicine to standard HFpEF treatments, so we don’t know if it’s better, worse, or equivalent to current medications. The research doesn’t tell us the optimal dose for humans or potential side effects in people. Long-term effects were not studied. Additionally, this is a single study, and results need to be confirmed by other independent research teams before clinical use in humans.
The Bottom Line
Based on this research, Shenfu Qiangxin pill shows promise for treating HFpEF, but current evidence is limited to animal studies. Confidence level: Low to Moderate for human application. People with HFpEF should continue following their doctor’s prescribed treatment plan. Those interested in exploring herbal medicine should discuss it with their cardiologist before making any changes. This research provides a foundation for future human clinical trials but should not yet guide treatment decisions.
Cardiologists and heart failure specialists should pay attention to this research as it suggests a new therapeutic approach for a difficult-to-treat condition. Patients with HFpEF and their families may find hope in these findings, but should understand that human studies are still needed. Researchers in both traditional medicine and modern cardiology should note how this work bridges ancient and modern approaches. People should NOT self-treat with this herbal medicine based on this study alone.
If this research leads to human clinical trials, it typically takes 5-10 years for a new treatment to move from animal studies to FDA approval. Patients should expect that any potential new treatment based on this research would not be widely available for several years. Benefits in the animal study appeared within the treatment period, but human responses may differ.
Frequently Asked Questions
Can I use Shenfu Qiangxin pill to treat my heart failure right now?
Not based on this research alone. While the 2026 study shows promise in mice, human clinical trials are needed before medical recommendations can be made. Consult your cardiologist about current approved treatments for your specific type of heart failure.
How does this herbal medicine work differently than standard heart failure drugs?
This herbal formula contains multiple ingredients that target different heart cell types simultaneously, addressing inflammation, scarring, and fluid drainage at once. Most standard medications focus on single targets, which may explain why this multi-component approach shows promise for complex diseases like HFpEF.
What is HFpEF and why is it hard to treat?
HFpEF (heart failure with preserved ejection fraction) is a type where the heart pumps normally but can’t relax properly, causing fluid buildup. It’s difficult to treat because multiple cell types malfunction simultaneously, and current medications typically target only one problem, leaving others unaddressed.
When will this herbal medicine be available for human patients?
This research is preliminary. If human clinical trials begin soon, it typically takes 5-10 years for a new treatment to receive regulatory approval. Patients should continue their current prescribed treatments while monitoring for future trial opportunities.
Are there side effects I should know about from this herbal medicine?
This animal study didn’t evaluate side effects in humans. Before considering any herbal treatment, discuss potential risks and interactions with your cardiologist, as herbal medicines can interact with heart medications and may cause adverse effects in some people.
Want to Apply This Research?
- Users with HFpEF could track daily symptoms (shortness of breath, fatigue, swelling) and heart rate variability to monitor disease progression. If they participate in future clinical trials of herbal treatments, they could log these metrics alongside treatment dates to identify patterns.
- While awaiting human studies, users could work with their doctor to optimize current HFpEF treatments and track adherence. The app could remind users to take prescribed medications, monitor fluid intake (important in heart failure), and track exercise tolerance—all while noting any interest in future herbal medicine trials.
- Establish a baseline of current symptoms and heart function measurements. If herbal treatments become available through clinical trials, users could compare monthly symptom scores and functional capacity (how far they can walk, for example) to detect improvements. Regular check-ins with their cardiologist would remain essential.
This article summarizes research findings from an animal study and should not be considered medical advice. Heart failure with preserved ejection fraction (HFpEF) is a serious medical condition requiring professional diagnosis and treatment. Do not start, stop, or change any heart medications without consulting your cardiologist. While Shenfu Qiangxin pill shows promise in laboratory studies, it has not been approved by the FDA for treating heart failure in humans, and human clinical trials are still needed. Herbal medicines can interact with prescription medications and may cause side effects. Always discuss any interest in herbal treatments with your healthcare provider before use. This research represents early-stage findings and should not guide treatment decisions until human studies are completed and reviewed by medical authorities.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.